Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Koch

Showing results (661-670 of 726) with videos related to

Pageof 73
Sort By:
Cancer Research|April 12, 2017
Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2<sup>+</sup> Breast CancerAriella B Hanker, Mónica Valeria Estrada, Giampaolo Bianchini, et al.
Blood|December 9, 1998
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study GroupH Tesch, V Diehl, B Lathan, et al.
Clinical Pharmacology and Therapeutics|August 29, 2024
A Pooled Population Pharmacokinetic Study of Oral and Intravenous Administration of Clavulanic Acid in Neonates and Infants: Targeting Effective Beta-Lactamase InhibitionStef Schouwenburg, Fleur M Keij, Gerdien A Tramper-Stranders, et al.
Hypertension (Dallas, Tex. : 1979)|March 28, 2022
Omeprazole Administration in Preterm Preeclampsia: a Randomized Controlled Trial to Study Its Effect on sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1), PlGF (Placental Growth Factor), and ET-1 (Endothelin-1)Rugina I Neuman, Milan D Baars, Langeza Saleh, et al.
Clinical Pharmacokinetics|May 13, 2020
Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and AdolescentsSanne M Kloosterboer, Karin M Egberts, Brenda C M de Winter, et al.
Chronobiology International|June 24, 2015
An observational study on disturbed peripheral circadian rhythms in hemodialysis patientsMarije Russcher, Inês Chaves, Karolina Lech, et al.
Pediatric Research|July 23, 2020
The bioavailability and maturing clearance of doxapram in preterm infantsRobert B Flint, Sinno H P Simons, Peter Andriessen, et al.
Contact Dermatitis|June 20, 1998
Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergyA Schnuch, G A Westphal, M M Müller, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 18, 2024
Population pharmacokinetics of intraperitoneal irinotecan and SN-38 in patients with peritoneal metastases from colorectal originPascale C S Rietveld, Sebastiaan D T Sassen, Niels A D Guchelaar, et al.
BMJ Open|April 25, 2025
Omission of dexamethasone in paclitaxel premedication regimens: protocol of the multicentre, randomised, non-inferiority DEXASTOP trialMichiel Zietse, Luuk C Aalders, Leontine E A M M Spierings, et al.
Pageof 73

Showing results (661-670 of 726) with videos related to

Sort By:
Pageof 73
Cancer Research|April 12, 2017
Extracellular Matrix/Integrin Signaling Promotes Resistance to Combined Inhibition of HER2 and PI3K in HER2<sup>+</sup> Breast CancerAriella B Hanker, Mónica Valeria Estrada, Giampaolo Bianchini, et al.
Blood|December 9, 1998
Moderate dose escalation for advanced stage Hodgkin's disease using the bleomycin, etoposide, adriamycin, cyclophosphamide, vincristine, procarbazine, and prednisone scheme and adjuvant radiotherapy: a study of the German Hodgkin's Lymphoma Study GroupH Tesch, V Diehl, B Lathan, et al.
Clinical Pharmacology and Therapeutics|August 29, 2024
A Pooled Population Pharmacokinetic Study of Oral and Intravenous Administration of Clavulanic Acid in Neonates and Infants: Targeting Effective Beta-Lactamase InhibitionStef Schouwenburg, Fleur M Keij, Gerdien A Tramper-Stranders, et al.
Hypertension (Dallas, Tex. : 1979)|March 28, 2022
Omeprazole Administration in Preterm Preeclampsia: a Randomized Controlled Trial to Study Its Effect on sFlt-1 (Soluble Fms-Like Tyrosine Kinase-1), PlGF (Placental Growth Factor), and ET-1 (Endothelin-1)Rugina I Neuman, Milan D Baars, Langeza Saleh, et al.
Clinical Pharmacokinetics|May 13, 2020
Pipamperone Population Pharmacokinetics Related to Effectiveness and Side Effects in Children and AdolescentsSanne M Kloosterboer, Karin M Egberts, Brenda C M de Winter, et al.
Chronobiology International|June 24, 2015
An observational study on disturbed peripheral circadian rhythms in hemodialysis patientsMarije Russcher, Inês Chaves, Karolina Lech, et al.
Pediatric Research|July 23, 2020
The bioavailability and maturing clearance of doxapram in preterm infantsRobert B Flint, Sinno H P Simons, Peter Andriessen, et al.
Contact Dermatitis|June 20, 1998
Genotype and phenotype of N-acetyltransferase 2 (NAT2) polymorphism in patients with contact allergyA Schnuch, G A Westphal, M M Müller, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 18, 2024
Population pharmacokinetics of intraperitoneal irinotecan and SN-38 in patients with peritoneal metastases from colorectal originPascale C S Rietveld, Sebastiaan D T Sassen, Niels A D Guchelaar, et al.
BMJ Open|April 25, 2025
Omission of dexamethasone in paclitaxel premedication regimens: protocol of the multicentre, randomised, non-inferiority DEXASTOP trialMichiel Zietse, Luuk C Aalders, Leontine E A M M Spierings, et al.
Pageof 73